AU4812393A - Use of rapamycin in the treatment of aids - Google Patents

Use of rapamycin in the treatment of aids

Info

Publication number
AU4812393A
AU4812393A AU48123/93A AU4812393A AU4812393A AU 4812393 A AU4812393 A AU 4812393A AU 48123/93 A AU48123/93 A AU 48123/93A AU 4812393 A AU4812393 A AU 4812393A AU 4812393 A AU4812393 A AU 4812393A
Authority
AU
Australia
Prior art keywords
rapamycin
aids
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48123/93A
Inventor
Claude Vezina
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shire Canada Inc
Original Assignee
IAF BioChem International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IAF BioChem International Inc filed Critical IAF BioChem International Inc
Publication of AU4812393A publication Critical patent/AU4812393A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
AU48123/93A 1992-09-03 1993-09-02 Use of rapamycin in the treatment of aids Abandoned AU4812393A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US93877492A 1992-09-03 1992-09-03
US938774 1992-09-03
US10282293A 1993-08-06 1993-08-06
US102822 1993-08-06
PCT/CA1993/000384 WO1994005300A1 (en) 1992-09-03 1993-09-02 Use of rapamycin in the treatment of aids

Publications (1)

Publication Number Publication Date
AU4812393A true AU4812393A (en) 1994-03-29

Family

ID=26799773

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48123/93A Abandoned AU4812393A (en) 1992-09-03 1993-09-02 Use of rapamycin in the treatment of aids

Country Status (2)

Country Link
AU (1) AU4812393A (en)
WO (1) WO1994005300A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141609B2 (en) 1992-08-25 2006-11-28 G.D. Searle & Co. α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
DK0656887T3 (en) 1992-08-25 1999-07-05 Searle & Co Hydroxyethylaminosulfonamides for use as inhibitors of retroviral proteases
US20020120130A1 (en) 1993-09-10 2002-08-29 Gilles Gosselin 2' or 3' -deoxy and 2', 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents
CA2637774C (en) * 1993-09-10 2011-07-19 Emory University Nucleosides with anti-hepatitis b virus activity
US5563145A (en) * 1994-12-07 1996-10-08 American Home Products Corporation Rapamycin 42-oximes and hydroxylamines
DE69636734T2 (en) 1995-06-07 2007-10-18 Emory University NUCLEOSIDE WITH ANTI-HEPATITIS B VIRUS EFFICACY
AU2003266152A1 (en) * 2002-09-13 2004-04-30 University Of Maryland Biotechnology COMPOSITIONS FOR INDUCING INCREASED LEVELS OF Beta-CHEMOKINES AND METHODS OF USE THEREFOR
AU2004251228B2 (en) * 2003-05-16 2008-04-24 University Of Maryland Biotechnology Institute Compositions for down-regulation of CCR5 expression and methods of use therefor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091389A (en) * 1991-04-23 1992-02-25 Merck & Co., Inc. Lipophilic macrolide useful as an immunosuppressant
US5093338A (en) * 1991-04-23 1992-03-03 Merck & Co., Inc. Lipophilic macrolide useful as an immunosuppressant

Also Published As

Publication number Publication date
WO1994005300A1 (en) 1994-03-17

Similar Documents

Publication Publication Date Title
AU5687896A (en) Use of alpha 1L-agonists in the treatment of incontinence
AU7545594A (en) Implantable device for the treatment of aedemas
AU5389194A (en) Wastewater treatment
AU5562494A (en) Alkylglyceramides and their use as surfactants
AU8154294A (en) Methods of inhibiting atrophy of the skin and vagina
AU3959193A (en) Heterocyclic compounds and their use in the treatment of type II-diabetes
AU4098393A (en) Laminate and use of the same
AU5590696A (en) Use of quinones in the treatment of cancer or AIDS
AU1556497A (en) Agents for the treatment and prevention of aids
AU2387097A (en) Substituted benzylamines and their use for the treatment of depression
AU5465594A (en) Aldonamides and their use as surfactants
AU1278295A (en) Wastewater treatment
AU4812393A (en) Use of rapamycin in the treatment of aids
AU8427091A (en) Gamma-carboxylase and methods of use
AU4100593A (en) Iminoalcohol-oxazolidine mixtures and their use
AU6723294A (en) Use of simmondsine
AU5340594A (en) Skin treatment
AU5737494A (en) Human thrombospondin-4
AU6927894A (en) 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions
AU1081897A (en) Heterocyclic compounds and their use
AU7874291A (en) Packaging-material body
AU5371694A (en) Use of the tarchonanthus camphoratus
AU4319393A (en) Use of indolocarbazols in aids treatment
AU6575894A (en) Body massager
AU3456793A (en) Macrocyclic compounds in the prophylactic treatment of aids